Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb7a
|
ENSMUSG00000035011.9 | zinc finger and BTB domain containing 7a |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_81134011_81134482 | Zbtb7a | 974 | 0.290999 | -0.73 | 2.4e-10 | Click! |
chr10_81143451_81143616 | Zbtb7a | 5580 | 0.075619 | -0.56 | 7.5e-06 | Click! |
chr10_81140694_81141139 | Zbtb7a | 2963 | 0.098694 | -0.54 | 1.8e-05 | Click! |
chr10_81135937_81136662 | Zbtb7a | 28 | 0.934029 | -0.54 | 1.9e-05 | Click! |
chr10_81135057_81135208 | Zbtb7a | 88 | 0.916083 | -0.50 | 9.8e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_124439906_124440949 | 29.64 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr19_61225302_61226760 | 23.18 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr6_91284995_91285433 | 19.13 |
Fbln2 |
fibulin 2 |
19335 |
0.17 |
chr7_57508956_57510254 | 15.55 |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
234 |
0.95 |
chr19_36553934_36555231 | 14.58 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr4_25799474_25800254 | 14.29 |
Fut9 |
fucosyltransferase 9 |
9 |
0.98 |
chr5_109556763_109557843 | 14.26 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr7_34570196_34571084 | 13.78 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr4_110050502_110051534 | 13.30 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr12_61522794_61523620 | 13.03 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
40 |
0.97 |
chr3_17793443_17793892 | 12.68 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr9_122571793_122572853 | 12.37 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr14_5388691_5389629 | 11.90 |
Gm3500 |
predicted gene 3500 |
111 |
0.95 |
chr5_37028014_37028420 | 11.86 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
118 |
0.96 |
chr2_153425549_153426538 | 11.52 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr14_6287027_6287952 | 11.34 |
Gm3411 |
predicted gene 3411 |
239 |
0.89 |
chr11_4572974_4574056 | 11.34 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr6_39871251_39871962 | 11.24 |
Tmem178b |
transmembrane protein 178B |
145 |
0.75 |
chr14_4181957_4182899 | 11.07 |
Gm2974 |
predicted gene 2974 |
148 |
0.94 |
chr3_32616403_32617072 | 10.96 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr14_7567758_7569131 | 10.95 |
Gm3558 |
predicted gene 3558 |
122 |
0.95 |
chr9_18473066_18474201 | 10.87 |
Zfp558 |
zinc finger protein 558 |
74 |
0.95 |
chr1_112416405_112416721 | 10.84 |
Gm18406 |
predicted gene, 18406 |
11708 |
0.27 |
chr14_55205168_55205319 | 10.57 |
Dhrs2 |
dehydrogenase/reductase member 2 |
16764 |
0.11 |
chr14_4726126_4727100 | 10.39 |
Gm3252 |
predicted gene 3252 |
162 |
0.93 |
chr17_13759899_13761731 | 10.00 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr11_69323471_69324558 | 9.97 |
Trappc1 |
trafficking protein particle complex 1 |
34 |
0.73 |
chr3_137057221_137057402 | 9.93 |
Gm26107 |
predicted gene, 26107 |
10581 |
0.26 |
chr10_79613505_79614566 | 9.91 |
C2cd4c |
C2 calcium-dependent domain containing 4C |
10 |
0.95 |
chr12_30372910_30373696 | 9.81 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr16_19761150_19761485 | 9.74 |
B3gnt5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
263 |
0.91 |
chr3_88214175_88214875 | 9.62 |
Gm3764 |
predicted gene 3764 |
30 |
0.87 |
chr15_75566838_75567525 | 9.52 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
35 |
0.96 |
chr18_35214941_35215148 | 9.52 |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
20 |
0.56 |
chr12_44329338_44330111 | 9.48 |
Nrcam |
neuronal cell adhesion molecule |
474 |
0.8 |
chr11_8864339_8864613 | 9.47 |
Pkd1l1 |
polycystic kidney disease 1 like 1 |
592 |
0.78 |
chr13_97071173_97072309 | 9.36 |
Fam169a |
family with sequence similarity 169, member A |
98 |
0.96 |
chr11_7213273_7214485 | 9.31 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
18 |
0.98 |
chr7_119720225_119720969 | 9.10 |
Thumpd1 |
THUMP domain containing 1 |
167 |
0.91 |
chr11_74590019_74590518 | 9.09 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
82 |
0.97 |
chr8_12323833_12323984 | 8.99 |
Gm33175 |
predicted gene, 33175 |
4428 |
0.19 |
chr15_85708879_85709635 | 8.93 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr12_44328644_44329298 | 8.91 |
Nrcam |
neuronal cell adhesion molecule |
12 |
0.98 |
chr14_73384624_73385557 | 8.80 |
Itm2b |
integral membrane protein 2B |
108 |
0.97 |
chr9_90269973_90270914 | 8.80 |
Tbc1d2b |
TBC1 domain family, member 2B |
326 |
0.88 |
chr18_32938695_32939361 | 8.71 |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
130 |
0.6 |
chr13_99516425_99517155 | 8.63 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr2_25305002_25305481 | 8.62 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
141 |
0.87 |
chr2_67565185_67565418 | 8.62 |
B3galt1 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
570 |
0.78 |
chr2_94246412_94247550 | 8.60 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3643 |
0.17 |
chr2_34771746_34772705 | 8.59 |
Hspa5 |
heat shock protein 5 |
126 |
0.95 |
chr8_4238910_4239597 | 8.57 |
Gm49320 |
predicted gene, 49320 |
388 |
0.44 |
chr1_37029164_37029564 | 8.57 |
Vwa3b |
von Willebrand factor A domain containing 3B |
20 |
0.98 |
chr10_81559146_81561402 | 8.47 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr14_34823193_34823513 | 8.46 |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
3245 |
0.25 |
chr18_62863617_62863829 | 8.46 |
Gm50128 |
predicted gene, 50128 |
58378 |
0.11 |
chr16_9995272_9995577 | 8.39 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
136 |
0.97 |
chr1_132007251_132008431 | 8.24 |
Elk4 |
ELK4, member of ETS oncogene family |
35 |
0.96 |
chr2_132029196_132030408 | 8.24 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr15_39197089_39197893 | 8.18 |
Rims2 |
regulating synaptic membrane exocytosis 2 |
770 |
0.61 |
chr9_114026283_114026988 | 8.13 |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
91 |
0.97 |
chr12_108916756_108916907 | 8.09 |
Wdr25 |
WD repeat domain 25 |
4099 |
0.15 |
chr2_132385204_132385458 | 8.02 |
Prokr2 |
prokineticin receptor 2 |
69 |
0.97 |
chr13_14522874_14523297 | 7.99 |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
20 |
0.92 |
chr1_88838754_88838920 | 7.96 |
Gm29337 |
predicted gene 29337 |
36573 |
0.16 |
chr10_87489779_87490093 | 7.93 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
3724 |
0.24 |
chr1_57643592_57643743 | 7.92 |
Gm17929 |
predicted gene, 17929 |
79616 |
0.09 |
chr15_89548106_89548620 | 7.84 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
737 |
0.54 |
chr4_116016940_116018214 | 7.83 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr3_34660502_34660751 | 7.81 |
Gm42693 |
predicted gene 42693 |
3663 |
0.14 |
chr2_14876087_14876291 | 7.79 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
1437 |
0.42 |
chr2_17730264_17731671 | 7.78 |
Nebl |
nebulette |
76 |
0.98 |
chr12_26414308_26415459 | 7.76 |
Mir6538 |
microRNA 6538 |
127 |
0.66 |
chr9_124422847_124423464 | 7.76 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
428 |
0.8 |
chr3_68072068_68072422 | 7.71 |
Schip1 |
schwannomin interacting protein 1 |
7443 |
0.3 |
chr14_14350947_14351733 | 7.63 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr14_7488846_7489218 | 7.58 |
Gm3752 |
predicted gene 3752 |
5270 |
0.15 |
chr3_107036269_107036464 | 7.51 |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
197 |
0.93 |
chr17_87746729_87746944 | 7.48 |
Msh2 |
mutS homolog 2 |
50295 |
0.12 |
chr2_146279531_146279776 | 7.44 |
Ralgapa2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
18278 |
0.16 |
chr5_65950673_65951149 | 7.32 |
4930480C01Rik |
RIKEN cDNA 4930480C01 gene |
394 |
0.76 |
chr1_38835547_38836894 | 7.31 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr9_98986138_98987021 | 7.22 |
Faim |
Fas apoptotic inhibitory molecule |
172 |
0.93 |
chr10_34206475_34207143 | 7.22 |
Dse |
dermatan sulfate epimerase |
268 |
0.86 |
chr10_92438739_92438890 | 7.22 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
37800 |
0.13 |
chr16_28445903_28447087 | 7.19 |
Fgf12 |
fibroblast growth factor 12 |
218 |
0.97 |
chr12_49384461_49384617 | 7.19 |
Gm43517 |
predicted gene 43517 |
635 |
0.55 |
chr3_45380711_45381562 | 7.18 |
Pcdh10 |
protocadherin 10 |
1497 |
0.34 |
chr14_60554058_60554987 | 7.17 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr2_104711782_104712014 | 7.16 |
Tcp11l1 |
t-complex 11 like 1 |
195 |
0.92 |
chr1_178529956_178530555 | 7.16 |
Kif26b |
kinesin family member 26B |
1130 |
0.58 |
chr3_30792734_30793388 | 7.13 |
Sec62 |
SEC62 homolog (S. cerevisiae) |
186 |
0.78 |
chr14_122474429_122474660 | 7.08 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
655 |
0.44 |
chr3_127695605_127695803 | 7.08 |
Gm16238 |
predicted gene 16238 |
3184 |
0.15 |
chr15_79402702_79403950 | 7.07 |
Tmem184b |
transmembrane protein 184b |
50 |
0.95 |
chr14_6038679_6038835 | 6.99 |
Gm8206 |
predicted gene 8206 |
548 |
0.63 |
chr10_77902919_77903521 | 6.98 |
Lrrc3 |
leucine rich repeat containing 3 |
684 |
0.44 |
chr14_3048629_3049241 | 6.97 |
Gm2897 |
predicted gene 2897 |
350 |
0.83 |
chr14_14345884_14346978 | 6.96 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr12_3364588_3366025 | 6.95 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr14_5501056_5501435 | 6.91 |
Gm3488 |
predicted gene, 3488 |
429 |
0.73 |
chr12_108333504_108334768 | 6.91 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr13_24279825_24280171 | 6.90 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
488 |
0.73 |
chr2_24761902_24762681 | 6.88 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
756 |
0.65 |
chr7_79500821_79500972 | 6.88 |
Mir9-3hg |
Mir9-3 host gene |
775 |
0.43 |
chr9_61872295_61872485 | 6.75 |
Gm19208 |
predicted gene, 19208 |
20686 |
0.19 |
chr2_173658978_173659962 | 6.75 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr11_80428777_80429451 | 6.74 |
Psmd11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
424 |
0.83 |
chr4_85205547_85206216 | 6.73 |
Sh3gl2 |
SH3-domain GRB2-like 2 |
346 |
0.9 |
chr18_60925459_60925693 | 6.72 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
42 |
0.97 |
chr1_175625831_175626095 | 6.71 |
Fh1 |
fumarate hydratase 1 |
328 |
0.87 |
chr13_96130906_96131482 | 6.71 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1383 |
0.35 |
chr6_122485766_122486276 | 6.68 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr10_79533095_79534301 | 6.68 |
Plpp2 |
phospholipid phosphatase 2 |
59 |
0.95 |
chr9_108460151_108461186 | 6.67 |
Ccdc71 |
coiled-coil domain containing 71 |
133 |
0.64 |
chr8_4217407_4217800 | 6.66 |
Prr36 |
proline rich 36 |
144 |
0.9 |
chr6_55451539_55452374 | 6.63 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
22 |
0.98 |
chr6_147475772_147476207 | 6.62 |
Ccdc91 |
coiled-coil domain containing 91 |
2 |
0.53 |
chr13_78203360_78204177 | 6.62 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
981 |
0.45 |
chr16_28564320_28565026 | 6.62 |
Fgf12 |
fibroblast growth factor 12 |
278 |
0.94 |
chr7_81493867_81494058 | 6.61 |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
37 |
0.95 |
chr14_6037512_6038662 | 6.60 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr17_46487160_46487489 | 6.58 |
Ttbk1 |
tau tubulin kinase 1 |
351 |
0.77 |
chr6_115135106_115135548 | 6.57 |
Syn2 |
synapsin II |
377 |
0.55 |
chr19_36056880_36057230 | 6.57 |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7 |
285 |
0.92 |
chr2_93956023_93956186 | 6.57 |
Gm13889 |
predicted gene 13889 |
945 |
0.48 |
chr8_46470414_46471778 | 6.54 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
24 |
0.97 |
chr7_6729309_6729829 | 6.54 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr14_7244047_7245236 | 6.52 |
Gm5456 |
predicted gene 5456 |
3199 |
0.18 |
chr11_101477785_101478185 | 6.51 |
Gm11625 |
predicted gene 11625 |
1759 |
0.15 |
chr14_4110111_4111235 | 6.48 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr13_73846884_73847811 | 6.46 |
Nkd2 |
naked cuticle 2 |
264 |
0.89 |
chr15_10011651_10011840 | 6.46 |
Prlr |
prolactin receptor |
165493 |
0.04 |
chr5_150593023_150594879 | 6.46 |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
182 |
0.88 |
chr6_55804035_55804262 | 6.42 |
Itprid1 |
ITPR interacting domain containing 1 |
32747 |
0.22 |
chr11_32087496_32088333 | 6.40 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr4_23787920_23788117 | 6.40 |
Gm11890 |
predicted gene 11890 |
127674 |
0.05 |
chr12_49383283_49383570 | 6.38 |
Foxg1 |
forkhead box G1 |
419 |
0.7 |
chr7_143296005_143296854 | 6.38 |
Kcnq1ot1 |
KCNQ1 overlapping transcript 1 |
120 |
0.93 |
chr13_51921111_51921334 | 6.35 |
Gm26651 |
predicted gene, 26651 |
51992 |
0.13 |
chr11_21571751_21572602 | 6.35 |
Mdh1 |
malate dehydrogenase 1, NAD (soluble) |
17 |
0.53 |
chr19_41114249_41114435 | 6.32 |
Opalin |
oligodendrocytic myelin paranodal and inner loop protein |
37229 |
0.17 |
chr2_94266234_94266385 | 6.31 |
Mir670hg |
MIR670 host gene (non-protein coding) |
1391 |
0.35 |
chr3_68870013_68870633 | 6.29 |
Gm17641 |
predicted gene, 17641 |
57 |
0.91 |
chr17_27203606_27204996 | 6.28 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr5_37245988_37246869 | 6.28 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr15_43869917_43870190 | 6.28 |
Tmem74 |
transmembrane protein 74 |
17 |
0.99 |
chr5_44537719_44537895 | 6.28 |
Ldb2 |
LIM domain binding 2 |
2710 |
0.2 |
chr12_116485218_116485891 | 6.26 |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
166 |
0.93 |
chr7_62376881_62377054 | 6.25 |
Magel2 |
melanoma antigen, family L, 2 |
43 |
0.97 |
chr1_74111472_74111987 | 6.25 |
Tns1 |
tensin 1 |
12718 |
0.15 |
chr17_73709677_73710009 | 6.24 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
223 |
0.95 |
chr8_88520850_88521212 | 6.24 |
Nkd1 |
naked cuticle 1 |
323 |
0.91 |
chr8_69832079_69833191 | 6.23 |
Pbx4 |
pre B cell leukemia homeobox 4 |
2 |
0.96 |
chr16_50732699_50733248 | 6.23 |
Dubr |
Dppa2 upstream binding RNA |
200 |
0.94 |
chr14_3331997_3332403 | 6.17 |
Gm2956 |
predicted gene 2956 |
427 |
0.78 |
chr14_4498574_4499972 | 6.15 |
Gm3173 |
predicted gene 3173 |
15485 |
0.11 |
chr14_7174792_7175177 | 6.12 |
Gm3512 |
predicted gene 3512 |
451 |
0.77 |
chr7_63757798_63758433 | 6.12 |
Otud7a |
OTU domain containing 7A |
3403 |
0.22 |
chr1_39576504_39577731 | 6.12 |
Rnf149 |
ring finger protein 149 |
186 |
0.9 |
chr1_176274614_176274863 | 6.11 |
Pld5 |
phospholipase D family, member 5 |
536 |
0.71 |
chr5_23675895_23676511 | 6.09 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr8_66687519_66687670 | 6.04 |
Npy5r |
neuropeptide Y receptor Y5 |
453 |
0.83 |
chr14_5460616_5460971 | 6.03 |
Gm3194 |
predicted gene 3194 |
5326 |
0.13 |
chr3_94465845_94466093 | 6.02 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
6953 |
0.08 |
chr2_28446566_28447382 | 6.01 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr7_69579254_69579507 | 6.00 |
Gm44535 |
predicted gene 44535 |
328 |
0.9 |
chr5_65106807_65107827 | 5.98 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr4_155774220_155774759 | 5.98 |
Vwa1 |
von Willebrand factor A domain containing 1 |
209 |
0.82 |
chrX_105121261_105121558 | 5.98 |
Magee1 |
melanoma antigen, family E, 1 |
1031 |
0.48 |
chr18_35964698_35964904 | 5.96 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
29 |
0.97 |
chr13_56774410_56774604 | 5.96 |
Gm45623 |
predicted gene 45623 |
20680 |
0.21 |
chr18_46212427_46212840 | 5.95 |
Trim36 |
tripartite motif-containing 36 |
26 |
0.98 |
chr10_39133560_39134579 | 5.94 |
Tube1 |
tubulin, epsilon 1 |
1 |
0.66 |
chr16_49319411_49319604 | 5.93 |
Gm5407 |
predicted gene 5407 |
21609 |
0.2 |
chr12_29938165_29938369 | 5.93 |
Pxdn |
peroxidasin |
217 |
0.96 |
chr13_13783865_13785053 | 5.92 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr12_91778477_91779525 | 5.91 |
Ston2 |
stonin 2 |
136 |
0.95 |
chr3_80802510_80803270 | 5.90 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr8_123411336_123412017 | 5.89 |
Tubb3 |
tubulin, beta 3 class III |
86 |
0.91 |
chr17_24689202_24689794 | 5.88 |
Syngr3 |
synaptogyrin 3 |
457 |
0.54 |
chr11_107794178_107794629 | 5.88 |
Cacng4 |
calcium channel, voltage-dependent, gamma subunit 4 |
154 |
0.84 |
chr8_4677704_4678740 | 5.87 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr3_56962631_56962829 | 5.87 |
Gm22269 |
predicted gene, 22269 |
91420 |
0.09 |
chr14_5880760_5880938 | 5.87 |
Gm8237 |
predicted gene 8237 |
467 |
0.69 |
chr6_119329664_119330446 | 5.87 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
702 |
0.44 |
chr10_70599218_70599723 | 5.86 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
179 |
0.96 |
chr13_78210050_78210256 | 5.85 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
7366 |
0.14 |
chr9_15045344_15045748 | 5.82 |
Panx1 |
pannexin 1 |
68 |
0.97 |
chr4_121097729_121098495 | 5.79 |
Zmpste24 |
zinc metallopeptidase, STE24 |
129 |
0.92 |
chr14_115092118_115092966 | 5.78 |
Gpc5 |
glypican 5 |
84 |
0.96 |
chr12_86989961_86990586 | 5.77 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
157 |
0.94 |
chr8_4492910_4494136 | 5.75 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr9_45370271_45370498 | 5.74 |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
58 |
0.96 |
chr17_35836572_35837313 | 5.73 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr14_5961062_5962084 | 5.73 |
Gm3248 |
predicted gene 3248 |
172 |
0.91 |
chr19_61227192_61227555 | 5.72 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
3 |
0.96 |
chr4_22477378_22477742 | 5.70 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10806 |
0.16 |
chr6_42692170_42692944 | 5.70 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
446 |
0.72 |
chr14_3651453_3651604 | 5.69 |
Gm3020 |
predicted gene 3020 |
502 |
0.71 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 18.2 | GO:0008355 | olfactory learning(GO:0008355) |
4.2 | 12.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.1 | 28.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.8 | 3.8 | GO:0021586 | pons maturation(GO:0021586) |
3.2 | 19.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.1 | 9.4 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.1 | 9.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
3.0 | 18.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.0 | 9.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.0 | 8.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.9 | 14.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.9 | 8.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.9 | 8.6 | GO:0033058 | directional locomotion(GO:0033058) |
2.8 | 2.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.7 | 8.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.6 | 7.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.6 | 7.8 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
2.6 | 7.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
2.5 | 5.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.5 | 10.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
2.5 | 57.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.4 | 7.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
2.4 | 7.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.4 | 7.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
2.4 | 9.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
2.4 | 7.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
2.3 | 6.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.3 | 6.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
2.3 | 4.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.3 | 6.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.2 | 2.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.1 | 2.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.1 | 6.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.1 | 6.3 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
2.1 | 6.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.1 | 2.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.1 | 6.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
2.0 | 14.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.0 | 8.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.0 | 6.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.0 | 6.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
2.0 | 6.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.0 | 5.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.9 | 7.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.8 | 5.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.8 | 1.8 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
1.8 | 5.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.8 | 5.4 | GO:0097503 | sialylation(GO:0097503) |
1.8 | 19.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.8 | 7.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.8 | 5.3 | GO:0001927 | exocyst assembly(GO:0001927) |
1.7 | 10.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.7 | 13.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.7 | 8.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.7 | 3.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
1.7 | 5.0 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.7 | 3.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.7 | 5.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.7 | 1.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.6 | 6.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.6 | 6.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.6 | 1.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.6 | 12.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 17.7 | GO:0036065 | fucosylation(GO:0036065) |
1.6 | 3.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.6 | 3.1 | GO:0046959 | habituation(GO:0046959) |
1.6 | 1.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.5 | 7.7 | GO:0015884 | folic acid transport(GO:0015884) |
1.5 | 1.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.5 | 4.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.5 | 6.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.5 | 10.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.5 | 9.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.5 | 4.5 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.5 | 3.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.5 | 4.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 4.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.5 | 1.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.4 | 4.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 8.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.4 | 5.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.4 | 4.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.4 | 4.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.4 | 2.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.4 | 2.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.4 | 2.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.4 | 1.4 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.4 | 4.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 7.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.4 | 8.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.4 | 1.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
1.4 | 2.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.4 | 5.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.4 | 5.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.4 | 5.5 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.4 | 2.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.4 | 2.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.3 | 5.4 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
1.3 | 2.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.3 | 5.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.3 | 14.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.3 | 10.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.3 | 9.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.3 | 3.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.3 | 2.6 | GO:1903935 | response to sodium arsenite(GO:1903935) |
1.3 | 3.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.3 | 1.3 | GO:1904339 | regulation of dopaminergic neuron differentiation(GO:1904338) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.3 | 2.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.3 | 3.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.3 | 2.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.3 | 11.3 | GO:0006983 | ER overload response(GO:0006983) |
1.3 | 3.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.3 | 5.0 | GO:0022038 | corpus callosum development(GO:0022038) |
1.2 | 5.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.2 | 3.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.2 | 8.6 | GO:0048242 | epinephrine secretion(GO:0048242) |
1.2 | 3.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.2 | 3.7 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.2 | 2.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.2 | 3.6 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.2 | 3.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.2 | 3.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 4.8 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.2 | 2.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
1.2 | 3.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.2 | 4.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.2 | 1.2 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
1.2 | 2.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.2 | 4.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.2 | 7.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 4.6 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 3.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.1 | 3.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.1 | 3.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.1 | 4.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.1 | 9.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.1 | 3.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.1 | 9.1 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.1 | 3.4 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.1 | 11.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.1 | 6.6 | GO:0016264 | gap junction assembly(GO:0016264) |
1.1 | 19.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 16.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.1 | 3.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 3.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.1 | 7.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.1 | 3.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.1 | 3.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.1 | 3.2 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 4.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.1 | 2.1 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.1 | 3.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 3.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
1.1 | 4.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.1 | 1.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.0 | 4.2 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 5.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.0 | 2.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 3.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
1.0 | 3.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.0 | 4.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.0 | 8.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.0 | 3.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.0 | 1.0 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.0 | 3.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.0 | 1.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.0 | 2.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.0 | 3.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.0 | 3.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.0 | 9.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.0 | 1.0 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
1.0 | 2.9 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
1.0 | 3.9 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.0 | 1.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 2.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.0 | 1.9 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.0 | 5.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.0 | 1.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.0 | 2.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.0 | 31.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 2.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 3.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.9 | 2.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 0.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 0.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 0.9 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.9 | 1.9 | GO:0050955 | thermoception(GO:0050955) |
0.9 | 2.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.9 | 7.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.9 | 1.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.9 | 1.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.9 | 3.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 1.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.9 | 2.7 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.9 | 0.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.9 | 1.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.9 | 2.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.9 | 2.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.9 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.9 | 2.6 | GO:0030242 | pexophagy(GO:0030242) |
0.9 | 3.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.9 | 12.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 1.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.9 | 3.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 4.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.9 | 6.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.9 | 2.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) convergent extension involved in organogenesis(GO:0060029) |
0.8 | 2.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 9.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.8 | 2.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 3.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.8 | 2.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 1.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.8 | 4.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.8 | 5.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.8 | 3.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.8 | 4.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.8 | 2.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.8 | 3.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.8 | 1.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.8 | 3.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.8 | 6.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.8 | 0.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.8 | 4.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.8 | 2.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.8 | 12.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.8 | 2.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.8 | 2.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.8 | 2.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 2.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.8 | 2.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.8 | 1.6 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.8 | 6.4 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.8 | 1.6 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.8 | 4.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 4.0 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.8 | 1.6 | GO:0021764 | amygdala development(GO:0021764) |
0.8 | 35.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.8 | 6.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.8 | 2.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.8 | 3.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.5 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.8 | 4.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.8 | 2.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.8 | 2.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.8 | 3.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.8 | 3.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.8 | 0.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.8 | 3.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.7 | 0.7 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 3.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.7 | 8.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.7 | 1.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.7 | 0.7 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.7 | 1.5 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.7 | 0.7 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.7 | 7.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 2.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 1.4 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 1.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 6.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 0.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.7 | 3.6 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.7 | 2.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 2.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.7 | 1.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 1.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.7 | 1.4 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.7 | 6.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.7 | 2.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 8.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 2.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 0.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.7 | 2.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.7 | 4.8 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.7 | 4.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 6.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.7 | 10.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.7 | 1.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.7 | 6.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.7 | 2.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 1.3 | GO:0060923 | cardiac cell fate commitment(GO:0060911) cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 5.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 32.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 4.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 3.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 3.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.7 | 2.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 51.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 3.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 8.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.6 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.6 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 0.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.6 | 3.8 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.6 | 1.9 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.6 | 3.2 | GO:0042637 | catagen(GO:0042637) |
0.6 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 2.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.6 | 1.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 1.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.6 | 0.6 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.6 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.6 | 1.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 1.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 2.4 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 4.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.6 | 0.6 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 1.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 0.6 | GO:0086009 | membrane repolarization(GO:0086009) |
0.6 | 41.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.6 | 2.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 2.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 1.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 1.7 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.6 | 4.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.6 | 5.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.7 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 1.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 2.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.6 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 1.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 3.8 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.5 | 1.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 2.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 1.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.5 | 8.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.5 | 1.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.5 | 1.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 1.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 2.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.6 | GO:0015755 | fructose transport(GO:0015755) |
0.5 | 2.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.5 | 2.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.5 | 1.6 | GO:1901419 | regulation of vitamin D receptor signaling pathway(GO:0070562) regulation of response to alcohol(GO:1901419) |
0.5 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.5 | 1.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 4.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 0.5 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.5 | 7.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 1.5 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.5 | 2.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 2.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.5 | 0.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 1.5 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.5 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 2.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 1.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 1.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 1.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.5 | 2.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.5 | 7.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 2.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 5.0 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.5 | 3.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 1.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.5 | 2.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.5 | 5.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 3.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.5 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.5 | 1.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 1.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 1.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 3.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 1.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.5 | 3.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 1.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 1.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 2.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.5 | 7.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.5 | 1.4 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.5 | 1.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 2.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.5 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 1.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 2.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.5 | 4.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.5 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 0.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.5 | 1.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 2.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.5 | 2.3 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.5 | 1.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.5 | 0.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 1.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 2.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 1.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 4.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 6.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.8 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.4 | 0.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 5.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.4 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 0.4 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 11.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 0.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 3.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 0.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.4 | 0.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 0.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 3.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.4 | 3.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 3.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 2.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 3.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 1.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 2.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 2.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.8 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 1.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 2.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 0.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 4.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 2.4 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.4 | 0.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.4 | 2.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 3.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 0.8 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.4 | 2.8 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 1.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 13.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.4 | 1.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 3.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 9.6 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.4 | 2.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 4.2 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 0.8 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.4 | 4.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 6.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 0.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.4 | 1.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 7.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 1.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.4 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.4 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 2.5 | GO:0060914 | heart formation(GO:0060914) |
0.4 | 0.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 2.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 7.1 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.4 | 1.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 4.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 1.0 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 1.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.3 | 0.7 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.3 | 1.0 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.3 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 5.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.3 | 8.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 4.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.3 | 1.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 2.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.7 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.3 | GO:0060440 | trachea formation(GO:0060440) |
0.3 | 2.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.7 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.3 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 1.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 3.6 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.3 | 1.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 2.6 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 3.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.9 | GO:0001895 | retina homeostasis(GO:0001895) |
0.3 | 1.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 1.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.0 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 4.1 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.3 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 3.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 1.8 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.3 | 0.6 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.3 | 1.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.3 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.3 | 0.6 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 0.9 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 2.7 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 0.3 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 5.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 3.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 1.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 0.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 4.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 2.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 0.9 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 0.9 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 2.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.1 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.3 | 1.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 0.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.3 | 2.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 1.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.3 | 1.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 0.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.3 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 0.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 3.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 0.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.9 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 3.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 1.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 0.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 6.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.3 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 6.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 2.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 2.8 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.3 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 13.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 2.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.8 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 0.5 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 1.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 2.0 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 2.7 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 0.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 4.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 3.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 3.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 1.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.2 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 1.6 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 3.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 1.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.7 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.2 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 1.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 1.3 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.4 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.8 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 1.9 | GO:0048265 | response to pain(GO:0048265) |
0.2 | 0.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.2 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.2 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.8 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.8 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.8 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 2.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.2 | GO:0001964 | startle response(GO:0001964) |
0.2 | 3.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 2.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.8 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.2 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 1.5 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.2 | 0.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.2 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 1.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 1.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 1.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.5 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.2 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.3 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 2.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.8 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.3 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 1.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.4 | GO:0042755 | eating behavior(GO:0042755) |
0.2 | 1.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.2 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.8 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.2 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.9 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 1.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.9 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.1 | 0.6 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 1.3 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.6 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 1.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.1 | 0.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.3 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 7.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.7 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 6.7 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.4 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.7 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.1 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.3 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.7 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.1 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:2000870 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
0.1 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.5 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.4 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.9 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 2.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.7 | GO:0042558 | pteridine-containing compound metabolic process(GO:0042558) |
0.1 | 0.2 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.5 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.2 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 2.8 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.8 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 3.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0090193 | positive regulation of glomerulus development(GO:0090193) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0031103 | axon regeneration(GO:0031103) |
0.1 | 0.2 | GO:0086003 | cardiac muscle cell contraction(GO:0086003) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 2.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 1.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.0 | 0.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.0 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.0 | 0.1 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.0 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 1.2 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.0 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0072534 | perineuronal net(GO:0072534) |
3.1 | 37.7 | GO:0043194 | axon initial segment(GO:0043194) |
3.0 | 36.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.5 | 45.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.2 | 6.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.2 | 8.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.1 | 21.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 11.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.8 | 9.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.8 | 1.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.7 | 5.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.6 | 4.9 | GO:0048179 | activin receptor complex(GO:0048179) |
1.4 | 13.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.4 | 12.5 | GO:0036156 | inner dynein arm(GO:0036156) |
1.4 | 40.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.4 | 86.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.4 | 9.5 | GO:0030008 | TRAPP complex(GO:0030008) |
1.4 | 5.4 | GO:0070876 | SOSS complex(GO:0070876) |
1.3 | 4.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.3 | 5.2 | GO:0045298 | tubulin complex(GO:0045298) |
1.3 | 34.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.3 | 5.1 | GO:0044308 | axonal spine(GO:0044308) |
1.3 | 10.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.2 | 4.9 | GO:0032021 | NELF complex(GO:0032021) |
1.2 | 4.7 | GO:0032437 | cuticular plate(GO:0032437) |
1.2 | 2.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.1 | 3.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 4.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.1 | 15.1 | GO:0034704 | calcium channel complex(GO:0034704) |
1.1 | 12.9 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.1 | 4.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.0 | 4.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.0 | 7.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.0 | 4.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 6.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.0 | 4.0 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 4.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.9 | 3.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 9.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 4.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 2.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 2.4 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 9.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.8 | 4.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 5.9 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 5.1 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 3.6 | GO:0097433 | dense body(GO:0097433) |
0.7 | 12.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 2.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 7.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.7 | 5.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 2.7 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 16.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 23.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 1.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 9.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 2.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.6 | 12.3 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 8.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.6 | 7.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.6 | 1.8 | GO:0036396 | MIS complex(GO:0036396) |
0.6 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 18.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 2.9 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 8.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 1.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 5.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 3.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 2.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.5 | 4.7 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.5 | 1.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 5.5 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 6.9 | GO:0044298 | cell body membrane(GO:0044298) |
0.5 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 2.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 66.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 13.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 32.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 2.4 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 6.9 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 5.0 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 3.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 6.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 6.4 | GO:0001741 | XY body(GO:0001741) |
0.4 | 3.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 29.8 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 25.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 5.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 4.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 51.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 2.0 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 4.9 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 3.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 1.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 6.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 1.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 1.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 4.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 1.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 10.8 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 3.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 2.4 | GO:0070187 | telosome(GO:0070187) |
0.3 | 1.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 2.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 2.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 3.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.3 | 2.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 13.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.3 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 10.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 1.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 1.1 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.5 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.3 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 2.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 0.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 3.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 6.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 7.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.2 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 19.6 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 5.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 2.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 2.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 3.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 3.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 3.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.7 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 2.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 5.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 2.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 12.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 3.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 12.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 38.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 1.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 130.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 19.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.6 | 18.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
3.6 | 10.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.2 | 9.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.2 | 12.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.1 | 24.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
3.0 | 39.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.9 | 2.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.9 | 8.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.8 | 8.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.7 | 13.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
2.5 | 7.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.5 | 7.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.4 | 9.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.4 | 11.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.4 | 7.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.3 | 27.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
2.1 | 17.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
2.1 | 24.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.0 | 20.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
2.0 | 13.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.9 | 5.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 7.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.8 | 3.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.7 | 5.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.6 | 11.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.6 | 8.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.6 | 12.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
1.6 | 4.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.6 | 25.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.5 | 14.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.5 | 1.5 | GO:0051870 | methotrexate binding(GO:0051870) |
1.4 | 20.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.4 | 2.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.4 | 2.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.4 | 2.8 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.4 | 7.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.4 | 6.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 6.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.4 | 4.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.3 | 4.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.3 | 17.0 | GO:0031005 | filamin binding(GO:0031005) |
1.3 | 7.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.3 | 7.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.3 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.2 | 11.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.2 | 32.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 3.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.2 | 17.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.2 | 5.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.2 | 4.6 | GO:0097001 | ceramide binding(GO:0097001) |
1.2 | 2.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.1 | 6.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.1 | 3.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.1 | 7.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.1 | 3.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 3.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
1.1 | 6.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 3.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 16.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 2.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.1 | 4.3 | GO:0038100 | nodal binding(GO:0038100) |
1.1 | 4.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 27.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.1 | 13.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.0 | 2.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 7.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 4.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 2.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.0 | 7.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.0 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 4.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 3.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.0 | 6.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.0 | 2.9 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.9 | 3.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.9 | 9.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 2.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 7.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.9 | 21.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.9 | 2.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.9 | 2.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.9 | 5.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.9 | 3.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.8 | 4.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.8 | 5.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 4.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 2.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.8 | 2.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 2.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.7 | 3.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.7 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 2.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 2.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 1.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 0.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.7 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 13.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 21.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.7 | 3.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 0.7 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.7 | 8.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.7 | 18.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.7 | 2.1 | GO:0089720 | caspase binding(GO:0089720) |
0.7 | 3.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.7 | 2.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 4.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.7 | 5.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 9.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 4.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.7 | 3.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 5.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 4.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.6 | 3.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.6 | 3.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 3.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.6 | 2.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 1.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 13.5 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.6 | 2.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.6 | 3.0 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.6 | 4.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.6 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 12.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.6 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.8 | GO:0018594 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.6 | 1.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 2.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 6.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.6 | 5.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.6 | 3.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 3.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 11.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.6 | 8.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 2.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 1.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 6.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 2.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 5.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 2.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 4.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 3.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.5 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 1.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 4.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 4.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.5 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 0.5 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.5 | 6.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 3.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 10.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.5 | 0.5 | GO:0030351 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.5 | 2.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 5.9 | GO:0031404 | chloride ion binding(GO:0031404) |
0.5 | 3.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 3.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 2.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 2.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.5 | 1.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.5 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 19.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 1.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 2.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 4.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 5.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 2.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 2.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 3.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 2.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 2.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 5.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 3.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.4 | 4.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.4 | 1.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 1.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 4.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 2.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 4.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 4.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.8 | GO:0018856 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.4 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 24.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 0.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 7.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 5.9 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 0.3 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.3 | 8.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 3.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.3 | 2.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 2.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 4.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 4.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 5.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 10.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 8.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 3.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 2.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 4.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 3.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 2.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 2.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 7.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 0.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 10.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 13.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 7.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 10.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 2.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 19.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 5.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 2.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 2.2 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.7 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 1.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 3.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.2 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.4 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 5.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 3.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 3.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.8 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 4.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.7 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.2 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.6 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 3.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 2.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 23.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 4.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 4.8 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 4.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 11.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 1.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 4.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 2.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.8 | GO:0004787 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 3.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 2.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 1.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 10.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 14.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 4.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.7 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 8.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 10.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 3.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.5 | 9.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 13.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 9.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 2.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 1.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 67.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 4.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 9.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 70.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 2.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 6.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 7.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 7.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 3.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 5.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 3.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 4.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 4.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 1.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 5.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 40.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
2.9 | 43.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.1 | 28.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 41.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.8 | 20.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.6 | 64.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.5 | 16.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.4 | 8.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.3 | 36.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.3 | 31.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.1 | 15.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.1 | 9.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 10.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 8.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.9 | 3.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.9 | 8.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.8 | 11.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.8 | 12.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.8 | 4.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.7 | 12.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.7 | 10.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 16.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 13.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.7 | 14.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 13.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 14.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 6.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.6 | 12.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.6 | 2.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 5.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 1.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 6.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 6.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 5.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 7.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 4.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 7.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 9.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.5 | 4.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 4.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.5 | 13.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 10.7 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 12.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 4.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.5 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 0.5 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.5 | 8.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 20.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 0.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 5.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 10.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 6.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 2.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 4.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 6.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 3.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 1.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 5.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 2.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 5.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 11.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.3 | 2.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 2.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 9.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 34.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 3.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 3.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 0.6 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.2 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 4.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.7 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 7.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |